OraSure Technologies (Nasdaq: OSUR) $9.58. OraSure Technologies rising today as Canaccord Genuity boosted its price target on the stock to $12 on a “report the company has visited with FDA this week to discuss feasibility to develop an Ebola test.”
Chimerix (Nasdaq: CMRX) $36.39. Chimerix provided an update on the company’s R&D programs, including the addition of a potential new product candidate, CMX16669, to its development pipeline. For more color, click here.
Straight Path Communications (NYSE: STRP) $21.40. Straight Path Communications continuing higher following Q4 results reported earlier in the week.
